Cargando…

New Therapeutic Strategies for Systemic Sclerosis—a Critical Analysis of the Literature

Systemic sclerosis (SSc) is a multi-system disease characterized by skin fibrosis and visceral disease. Therapy is organ and pathogenesis targeted. In this review, we describe novel strategies in the treatment of SSc. Utilizing the MEDLINE and the COCHRANE REGISTRY, we identified open trials, contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zandman-Goddard, Gisele, Tweezer-Zaks, Nurit, Shoenfeld, Yehuda
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275417/ https://www.ncbi.nlm.nih.gov/pubmed/16295521 http://dx.doi.org/10.1080/17402520500233437

Ejemplares similares

Biologic therapy for autoimmune diseases: an update
por: Rosman, Ziv, et al.
Publicado: (2013)

Prolactin and Autoimmunity
por: Borba, Vânia Vieira, et al.
Publicado: (2018)

The Homogeneous Multiplexed System-a New Method for Autoantibody Profile in Systemic Lupus Erythematosus
por: Zandman-Goddard, Gisele, et al.
Publicado: (2005)

Neuropsychiatric lupus: a mosaic of clinical presentations
por: Kivity, Shaye, et al.
Publicado: (2015)

Autoimmunity and COVID-19 – The microbiotal connection
por: Katz-Agranov, Nurit, et al.
Publicado: (2021)

The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome
por: Rosário, Cristina, et al.
Publicado: (2013)

Elevated titers of anti-ribosomal-P antibodies in systemic lupus erythematosus
por: Zandman-Goddard, G, et al.
Publicado: (2005)

The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis
por: Shovman, O., et al.
Publicado: (2005)

Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form
por: Kolitz, Tamara, et al.
Publicado: (2019)

Old and new therapeutic strategies in systemic sclerosis (Review)
por: Bobeica, Carmen, et al.
Publicado: (2022)

The impact of facility characteristics on the use of antipsychotic medications in nursing homes: a cross-sectional study
por: Frankenthal, Dvora, et al.
Publicado: (2016)

Elevated anti-serum amyloid P component (SAP) antibodies in SLE patients
por: Zandman-Goddard, G, et al.
Publicado: (2003)

Erdheim-Chester Disease: a comprehensive review of the literature
por: Mazor, Roei D, et al.
Publicado: (2013)

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis
por: Gumkowska-Sroka, Olga, et al.
Publicado: (2023)

Systemic Lupus Erythematosus 2014
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Comment on: Dietary yeast reduce inflammation in central nerve system via microflora
por: Perricone, Carlo, et al.
Publicado: (2015)

Video Q&A: what is ASIA? An interview with Yehuda Shoenfeld
por: Shoenfeld, Yehuda
Publicado: (2013)

Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning
por: Shoenfeld, Yehuda
Publicado: (2020)

Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review
por: Meridor, Katya, et al.
Publicado: (2021)

Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the “Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants”: Case Report and Literature Review
por: Tomljenovic, Lucija, et al.
Publicado: (2014)

Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature
por: Kivity, Shaye, et al.
Publicado: (2009)

Dysregulation of G protein-coupled receptors of the autonomic nervous system, adrenergic and muscarinic acetylcholine receptors, in patients with autoimmune dysautonomic-related disorders
por: Halpert, Gilad, et al.
Publicado: (2020)

Autoimmunity, COVID-19 Omicron Variant, and Olfactory Dysfunction: A Literature Review
por: Patt, Yonatan Shneor, et al.
Publicado: (2023)

Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis
por: Ojeda-Hernández, Doddy Denise, et al.
Publicado: (2022)

Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting
por: Selmi, Carlo, et al.
Publicado: (2014)

SARS-CoV-2, the autoimmune virus
por: Halpert, Gilad, et al.
Publicado: (2020)

Medical, Genomic, and Evolutionary Aspects of the Peptide Sharing between Pathogens, Primates, and Humans
por: Kanduc, Darja, et al.
Publicado: (2020)

From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
por: Kanduc, Darja, et al.
Publicado: (2020)

Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine
por: Kanduc, Darja, et al.
Publicado: (2020)

On the molecular determinants of the SARS-CoV-2 attack
por: Kanduc, Darja, et al.
Publicado: (2020)

Post-COVID syndrome: the aftershock of SARS-CoV-2
por: Dotan, Arad, et al.
Publicado: (2022)

Perspectives on vaccine induced thrombotic thrombocytopenia
por: Dotan, Arad, et al.
Publicado: (2021)

Autoimmune Autonomic Dysfunction Syndromes: Potential Involvement and Pathophysiology Related to Complex Regional Pain Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, Silicone Breast Implant–Related Symptoms and Post-COVID Syndrome
por: Mahroum, Naim, et al.
Publicado: (2022)

Shared 6mer Peptides of Human and Omicron (21K and 21L) at SARS-CoV-2 Mutation Sites
por: Adiguzel, Yekbun, et al.
Publicado: (2022)

Editorial for “Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form”
por: Dotan, Arad, et al.
Publicado: (2023)

Multiple Sclerosis: Therapeutic Strategies on the Horizon
por: Talanki Manjunatha, Ramya, et al.
Publicado: (2022)

Microprocessors: From Chips to Systems
por: Zaks, Rodnay
Publicado: (1977)

Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies
por: Fagone, Paolo, et al.
Publicado: (2020)

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
por: Tan, Yossan-Var, et al.
Publicado: (2011)

Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature
por: Erez, Daniel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p303mkpogiaj3criam6bgldv1q